English
Segment disclosures
Company overviewSOLVENTUM CORPORATION
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Dental Solutions Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:DentalSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 396000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 750000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 354000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1349000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 340000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1006000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 338000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 667000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 328000000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1295000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 313000000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 979000000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 331000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 666000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 335000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1329000000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 331000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1023000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 351000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 692000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 341000000 | USD | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1327000000 | USD | 20250228 | Open filing evidence |
Operating Segments · Health Information Systems Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:HealthInformationSystemsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 354000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 696000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 342000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1360000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 345000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1012000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 339000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 667000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 329000000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1306000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 326000000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 971000000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 328000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 645000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 317000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1285000000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 321000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 953000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 316000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 632000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 316000000 | USD | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1227000000 | USD | 20250228 | Open filing evidence |
Operating Segments · Med Surg Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1372000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2607000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1234000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 4817000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1206000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3581000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1218000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2375000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1157000000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4637000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1182000000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3463000000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1162000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2281000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1119000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4632000000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1180000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3464000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1161000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2284000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1123000000 | USD | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4585000000 | USD | 20250228 | Open filing evidence |
Operating Segments · Med Surg Segment · Advanced Wound Care
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 448000000 | USD | 20250509 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 441000000 | USD | 20250509 | Open filing evidence |
Operating Segments · Med Surg Segment · Infection Prevention And Surgical Solutions
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 710000000 | USD | 20250509 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 678000000 | USD | 20250509 | Open filing evidence |
Operating Segments · Purification And Filtration Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=solv:PurificationAndFiltrationSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 497000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 128000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 497000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 189000000 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 369000000 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 180000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 709000000 Restated | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 180000000 Restated | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 532000000 Restated | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 238000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 483000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 245000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 689000000 Restated | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 242000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 721000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 248000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 479000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 231000000 | USD | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 991000000 | USD | 20250228 | Open filing evidence |
Operating Segments · Advanced Wound Care · Med Surg Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 497000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1883000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 485000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1400000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 467000000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 915000000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 448000000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1835000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 468000000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1369000000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 460000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 901000000 | USD | 20250808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1826000000 | USD | 20260227 | Open filing evidence |
Operating Segments · Infection Prevention And Surgical Solutions · Med Surg Segment
Consolidation Items · Subsegments · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 737000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2934000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 722000000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2182000000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 750000000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1460000000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 710000000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2802000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 713000000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2093000000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 702000000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1380000000 | USD | 20250808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2805000000 | USD | 20260227 | Open filing evidence |
Dental Solutions Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:DentalSolutionsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 317000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1067000000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 340000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1006000000 | USD | 20261105 | Open filing evidence |
Health Information Systems Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:HealthInformationSystemsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 356000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1052000000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 345000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1012000000 | USD | 20261105 | Open filing evidence |
Med Surg Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1211000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 3818000000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1206000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3581000000 | USD | 20261105 | Open filing evidence |
Med Surg Segment · Advanced Wound Care · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:AdvancedWoundCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 528000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1561000000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 537000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1034000000 | USD | 20260805 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 485000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1400000000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 467000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 915000000 | USD | 20260805 | Open filing evidence |
Med Surg Segment · Infection Prevention And Surgical Solutions · Operating Segments
Statement Business Segments · Subsegments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:MedSurgSegmentMember;us-gaap:SubsegmentsAxis=solv:InfectionPreventionAndSurgicalSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 683000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2256000000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 836000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1573000000 | USD | 20260805 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 722000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2182000000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 750000000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1460000000 | USD | 20260805 | Open filing evidence |
Purification And Filtration Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=solv:PurificationAndFiltrationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 128000000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 497000000 | USD | 20261105 | Open filing evidence |